Combined application of bevacizumab and PD-1 blockade displays durable treatment effects by increasing the infiltration and cytotoxic function of CD8+ T cells in lung cancer

Immunotherapy, Ahead of Print.

Source: Immunotherapy - May 16, 2022 Category: Allergy & Immunology Authors: Yanxia Liu Tongmei Zhang Lina Zhang Cong Zhao Zhiyun Zhang Ziyu Wang Meng Gu Weiying Li Baolan Li Source Type: research